Sanofi H1 2015 Results - Interview with CEO Olivier Brandicourt

PARIS, July 30, 2015 /PRNewswire/ --

Sanofi, a global and diversified healthcare leader, reports results for the second quarter of 2015. CEO Olivier Brandicourt comments on the group's results and its performance in different businesses.

Watch video interview and read transcript: 

http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire

Topics covered in the interview include: 

- Q2 results

- Performance drivers

- Diabetes

- Praluent

- Innovation

- Immuno-oncology

About Sanofi 

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

SOURCE Sanofi